Loading clinical trials...
Loading clinical trials...
The purpose of this study is to find out if baricitinib can delay the onset of clinical type 1 diabetes (T1D) in people who are at high risk to develop T1D. Participation in the study will last up to ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
CONTACT
1-317-615-4559[email protected]Lead Sponsor
Eli Lilly and Company
NCT06807190 · Diabetes Mellitus, Type 1
NCT07160816 · Diabetes Mellitus, Type 1
NCT04786262 · Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, and more
NCT07478211 · Diabetes Mellitus, Type 1, Energy Metabolism
NCT06748963 · Diabetes Mellitus, Type 1
Tallahassee Memorial HealthCare
Tallahassee, Florida
University of South Florida
Tampa, Florida
University of Iowa
Iowa City, Iowa
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions